Análisis opcionales del producto
Con tu permiso, usamos análisis limitados y respetuosos con la privacidad para entender qué recorridos de investigación funcionan. No usamos rastreadores publicitarios ni grabación de sesiones. Puedes cambiar esta opción en Preferencias. Lee la Política de privacidad.
KeyCorp's published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $21.3B | |
|---|---|---|
| Revenue (ttm) | 7.6B | |
| Net income (ttm) | 2B | |
| EPS (ttm) | $1.82 | |
| Shares out | 1.1B | |
| P/E (trailing) | 11.6x | |
| P/E (forward) | 9.9x | |
| Dividend | $0.82 (3.86%) | |
| Volume | 15,679,438 | |
| Beta | 1.09 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $1.82B | $1.59B | $1.44B | $1.64B | $1.75B | -1.0% |
| Gross profit | $7.46B | $7.03B | $5.73B | $4.06B | $6.97B | -1.7% |
| Operating income | $3.25B | $3.22B | $1.16B | $-306.0M | $2.30B | -8.3% |
| Net income | $2.63B | $1.92B | $967.0M | $-161.0M | $1.83B | -8.6% |
| EPS (diluted) | $2.63 | $1.93 | $0.88 | $-0.32 | $1.52 | -12.8% |
| EBITDA | $3.29B | $3.36B | $1.31B | $-233.0M | $2.33B | -8.3% |
| R&D | — | — | — | — | — | — |
| SG&A | $2.69B | $2.66B | $2.66B | $2.78B | $3.20B | +4.4% |
Recent company headlines from major financial publishers.
The Base scenario reflects the modal expected operating path. Structural fixed-rate repricing across the asset pipeline steadily lifts net interest margin into the guided range by late FY2026. Controlled overhead expansion generates positive operating leverage, advancing diluted EPS toward consensus targets in FY2026 and FY2027. Capital generation funds the planned share repurchase program while maintaining robust regulatory capital ratios.
In the Bull scenario, KeyCorp accelerates fixed-rate asset reinvestment at premium yields while deposit costs fall faster than expected due to disciplined beta management. Commercial borrowing surges across KeyBanc Capital Markets verticals, lifting C&I loan growth and investment banking fees. Operating efficiency improves rapidly, driving ROTCE expansion and supporting enhanced capital return, propelling valuation toward $35.57.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 7.2% | $25.0 | $26.2 | $27.6 | $29.4 | $31.6 |
| 8.0% | $22.9 | $23.8 | $24.9 | $26.2 | $27.7 |
| 8.7% | $21.2 | $21.9 | $22.8 | $23.7 | $24.8 |
| 9.5% | $19.8 | $20.4 | $21.0 | $21.7 | $22.6 |
| 10.2% | $18.6 | $19.1 | $19.6 | $20.1 | $20.8 |
Upcoming earnings date and setup when available.
La calificación que llevaba la edición de análisis publicada cada mes. Una calificación compara el precio en la fecha del análisis con el valor razonable; no es un registro de si la valoración acertó.
| Año | ene | feb | mar | abr | may | jun | jul | ago | sept | oct | nov | dic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
